APA

Peirs S., Matthijssens F., Goossens S., Van de Walle I., Ruggero K., de Bock C. E., Degryse S., Canté-Barrett K., Briot D., Clappier E., Lammens T., De Moerloose B., Benoit Y., Poppe B., Meijerink J. P., Cools J., Soulier J., Rabbitts T. H., Taghon T., Speleman F. & Van Vlierberghe P. (20150220). ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia. : Blood.

Chicago

Peirs Sofie, Matthijssens Filip, Goossens Steven, Van de Walle Inge, Ruggero Katia, de Bock Charles E, Degryse Sandrine, Canté-Barrett Kirsten, Briot Delphine, Clappier Emmanuelle, Lammens Tim, De Moerloose Barbara, Benoit Yves, Poppe Bruce, Meijerink Jules P, Cools Jan, Soulier Jean, Rabbitts Terence H, Taghon Tom, Speleman Frank and Van Vlierberghe Pieter. 20150220. ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia. : Blood.

Harvard

Peirs S., Matthijssens F., Goossens S., Van de Walle I., Ruggero K., de Bock C. E., Degryse S., Canté-Barrett K., Briot D., Clappier E., Lammens T., De Moerloose B., Benoit Y., Poppe B., Meijerink J. P., Cools J., Soulier J., Rabbitts T. H., Taghon T., Speleman F. and Van Vlierberghe P. (20150220). ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia. : Blood.

MLA

Peirs Sofie, Matthijssens Filip, Goossens Steven, Van de Walle Inge, Ruggero Katia, de Bock Charles E, Degryse Sandrine, Canté-Barrett Kirsten, Briot Delphine, Clappier Emmanuelle, Lammens Tim, De Moerloose Barbara, Benoit Yves, Poppe Bruce, Meijerink Jules P, Cools Jan, Soulier Jean, Rabbitts Terence H, Taghon Tom, Speleman Frank and Van Vlierberghe Pieter. ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia. : Blood. 20150220.